Agenus to Present agenT-797 Long-Term Data at SITC 2026
AGenus said it will present BOT+BAL long-term survival data and translational research with agenT-797 in colorectal cancer at SITC 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Agenus to Present Colorectal Cancer Data at SITC 2026
Agenus Inc. announced that two posters highlighting research on botensilimab (BOT) in combination with balstilimab (BAL) have been accepted for presentation at SITC 2026. The presentations will cover long-term survival data for BOT+BAL and translational research with agenT-797 in colorectal cancer.